No. This is a catalog-clarity page only. The approved drug label and qualified clinical or pharmacy approval remain required for prescription-drug information.
Product page improvement
From incomplete Rx fields to a clearer prescription-drug product record.
A stronger regulated catalog page should keep identity, strength, package, storage, identifiers, and compliance guardrails clear without adding medical advice.
Product page draft for review
LANTUS SoloStar Insulin Glargine Injection U-100, 3 mL Prefilled Pen, Carton of 5
This LANTUS SoloStar record separates brand, generic name, strength, dosage form, route, NDC, package size, storage, manufacturer, and Rx-only status for pharmacy catalog review.
| Item Number | NDC 0088-2219-05 |
|---|---|
| Unit | Carton of 5 prefilled pens |
Regulated product record
Prescription-drug catalog pages need a different standard than ordinary online store pages. The job is not to invent benefits, dosing, switching, substitution, or treatment claims. The job is to keep label-backed identity, package, storage, and compliance fields clear for qualified buyers and required approvals.
For LANTUS SoloStar, the record keeps brand display, generic name, NDC, route, dosage form, package, strength, storage handling, manufacturer, and compliance status in separate fields.
Label-backed fields
- Human prescription drug record with Rx-only status kept visible.
- Strength captured as insulin glargine 100 units/mL (U-100).
- Package captured as five 3 mL single-patient-use SoloStar prefilled pens per carton.
- NDC 0088-2219-05 identifies the five-pen carton package.
- Storage and handling details are kept separate so they can be checked against pharmacist or regulatory approval.
- No dosing, substitution, treatment, or medical advice is included.
Good fit
- Pharmacy, health-system, medical online store, and regulated catalog teams that need cleaner prescription-drug records.
- Catalog owners separating brand, generic name, manufacturer, NDC, dosage form, route, package, and storage fields.
- Prescription-drug records that need controlled review before they appear in a catalog, product file, or pharmacy feed.
- Regulated products that require checked identity, package, storage, and handling fields before approval.
Prescription catalog questions
The NDC helps identify the exact package. In this example, NDC 0088-2219-05 maps to the five-pen LANTUS SoloStar carton.
The record separates unused refrigeration, do-not-freeze handling, heat and light protection, and in-use timing so the details can be checked against the approved label.
Dosing, substitution, clinical, and regulatory language must come from approved sources and be approved by qualified people before publishing.
Prescription product fields
| Brand Display | LANTUS SoloStar |
|---|---|
| Generic Name | insulin glargine |
| Manufacturer/Labeler | sanofi-aventis U.S. LLC |
| Product Type | Human prescription drug |
| Prescription Status | Rx only |
| Dosage Form | Injection, solution |
| Route | Subcutaneous |
| Strength | 100 units/mL (U-100) |
| Package NDC | 0088-2219-05 |
| Package | 5 single-patient-use 3 mL SoloStar prefilled pens per carton |
| Needles | Not included |
| Unused Storage | Refrigerate at 36°F to 46°F (2°C to 8°C); do not freeze |
| Handling | Protect from direct heat and light |
| In-Use Timing | Use within 28 days after initial use |
| Compliance Gate | Pharmacist or regulatory approval before publishing |
| Blocked Copy | No dosing, switching, substitution, treatment, or medical-advice claims |
Proof boundary
What this prescription drugs example proves.
This prescription drugs example shows the starting record, buyer details added, page draft, and checks still needed before live use.
Shown here
- The prescription drugs page gaps and known product facts.
- Prescription drugs buyer details grouped before the page is written.
- Prescription drugs title, summary, sections, FAQ, specs, and search fields ready for team review.
Before live use
- Merchant approval of the prescription drugs source facts and product details.
- Current package or manufacturer confirmation for prescription drugs claims, fit, or regulated details.
- Prescription drugs image rights, brand rules, and final launch approval.
Not claimed
- Customer-specific performance claims.
- Search placement, traffic lift, or AI citation outcomes.
- Marketplace approval or policy decisions.
Source note
Source basis for LANTUS SoloStar Insulin Glargine Injection.
Use these notes to separate the inputs behind LANTUS SoloStar Insulin Glargine Injection from the checks a live merchant page still needs.
Source basis
- NDC, brand, generic name, strength, package, route, dosage form, storage, manufacturer, and Rx-only fields used in the example.
- Regulated fields are shown without dosing, substitution, or treatment advice.
Review before use
- Confirm the current approved label, package, storage, image rights, and pharmacy or regulatory review requirements.
- Approve all regulated language before any live catalog use.
Not claimed here
- No dosing, treatment, substitution, or patient guidance.
- No pharmacy compliance approval.
Before and after
See the prescription drugs page change side by side.
The before view shows the thin product information a shopper would have to decode. The after view shows the stronger buyer page your team can review before it moves forward.
LANTUS SoloStar Insulin Glargine Injection
The weak record names the medication and a strength, but it does not separate the brand, generic name, NDC, package, route, dosage form, storage rules, labeler, or compliance requirements.
- LANTUS PEN
- insulin glargine
- 100 units/mL
- 3 mL pen
- Keep cold
- NDC and package size
- Route and dosage form
- Rx-only and compliance status
- Unused and in-use storage details
- Manufacturer, labeler, and no-medical-advice guardrails
| Item | NDC 0088-2219-05 |
|---|---|
| Unit | Carton of 5 prefilled pens |
| Vertical | Prescription drugs |
LANTUS SoloStar Insulin Glargine Injection U-100, 3 mL Prefilled Pen, Carton of 5
This LANTUS SoloStar record separates brand, generic name, strength, dosage form, route, NDC, package size, storage, manufacturer, and Rx-only status for pharmacy catalog review.
- Human prescription drug record with Rx-only status kept visible.
- Strength captured as insulin glargine 100 units/mL (U-100).
- Package captured as five 3 mL single-patient-use SoloStar prefilled pens per carton.
- NDC 0088-2219-05 identifies the five-pen carton package.
- Storage and handling details are kept separate so they can be checked against pharmacist or regulatory approval.
No. This is a catalog-clarity page only. The approved drug label and qualified clinical or pharmacy approval remain required for prescription-drug information.
The NDC helps identify the exact package. In this example, NDC 0088-2219-05 maps to the five-pen LANTUS SoloStar carton.
The record separates unused refrigeration, do-not-freeze handling, heat and light protection, and in-use timing so the details can be checked against the approved label.
| Brand Display | LANTUS SoloStar |
|---|---|
| Generic Name | insulin glargine |
| Manufacturer/Labeler | sanofi-aventis U.S. LLC |
| Product Type | Human prescription drug |
| Prescription Status | Rx only |
From thin prescription drugs data to a stronger buyer page.
The example shows incomplete Rx fields becoming a regulated catalog record focused on identity, package, storage, and approval boundaries.
Stage 1
Rx fields without regulated-record structure
The starting record names a drug, strength, and cold-storage hint, but it does not separate identity, NDC, package, route, dosage form, storage, and approval guardrails.
- NDC and package size
- Route and dosage form
- Rx-only and compliance status
- Unused and in-use storage details
Stage 2
Label-backed identity, package, storage, and review gates
The page improves by separating brand, generic name, NDC, strength, route, package, storage, and blocked medical-advice language.
- Drug identity
- Strength and package
- Storage and handling
- Compliance guardrails
Stage 3
A prescription record without medical advice
The after page keeps catalog facts clear while avoiding dosing, treatment, switching, substitution, or compliance promises.
- Brand, generic name, NDC, strength, route, and package fields
- Unused and in-use storage fields for review
- Visible Rx-only and no-medical-advice boundaries
Prescription drugs buyer details added
These prescription-record details keep label-backed facts separate from copy that would require pharmacy, clinical, or regulatory approval.
Drug identity
5 drug identity details help catalog teams verify regulated identity, package, storage, and blocked-claim boundaries.
Strength and package
5 strength and package details help catalog teams verify regulated identity, package, storage, and blocked-claim boundaries.
Storage and handling
4 storage and handling details help catalog teams verify regulated identity, package, storage, and blocked-claim boundaries.
Compliance guardrails
4 compliance guardrails details help catalog teams verify regulated identity, package, storage, and blocked-claim boundaries.
What improves in this prescription drugs example
The after record shows how XEVRIN can make regulated product fields clearer without creating medical advice or unsupported compliance claims.
| Field group | Current gap | Buyer detail added | Why it matters |
|---|---|---|---|
| Drug identity | LANTUS PEN | Brand, generic name, dosage form, route, prescription status, and labeler separated | A regulated product record that is easier for pharmacy buyers and catalog teams to understand |
| Package and identifiers | 3 mL pen | NDC 0088-2219-05, five 3 mL SoloStar prefilled pens per carton, needles not included | Cleaner product file and catalog fields for the exact sellable package |
| Strength | 100 units/mL | Strength normalized as insulin glargine 100 units/mL (U-100) | Less ambiguity between brand, generic name, concentration, dosage form, and package |
| Storage and handling | Keep cold | Unused refrigeration range, do-not-freeze handling, heat/light protection, and in-use timing | Important handling details are separated instead of buried in a short note |
Destination package checks for NDC 0088-2219-05
Amazon + Walmart
Your store page stays buyer-facing. Marketplace outputs are separate field packages for Amazon and Walmart, prepared for destination rules, validation checks, and merchant-controlled values.
AmazonRestricted-category checks
Keep NDC, package, storage, Rx status, and compliance gates separate before any marketplace decision.
EligibilityNDC/packageStorageQualified approval
WalmartRestricted-category checks
Prepare regulated product fields only after pharmacy, legal, and seller-program requirements are confirmed.
EligibilityRegulated fieldsProgram rulesQualified approval
Compare another prescription drugs product.
Compare this draft with the example library, the product overview, or the demo path.
Next step
Use XEVRIN on a prescription drugs product like this.
Request a workflow review to see how XEVRIN would use your product information for clearer pages, answers, and approved files.